These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 28535494)

  • 1. Overdiagnosis in breast cancer screening: The impact of study design and calculations.
    Lynge E; Beau AB; Christiansen P; von Euler-Chelpin M; Kroman N; Njor S; Vejborg I
    Eur J Cancer; 2017 Jul; 80():26-29. PubMed ID: 28535494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis.
    Jørgensen KJ; Gøtzsche PC; Kalager M; Zahl PH
    Ann Intern Med; 2017 Mar; 166(5):313-323. PubMed ID: 28114661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Discrepancies and overdiagnosis in breast cancer organized screening. A "methodology" systematic review].
    Gocko X; Leclerq M; Plotton C
    Rev Epidemiol Sante Publique; 2018 Nov; 66(6):395-403. PubMed ID: 30316554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer incidence trends in Norway and estimates of overdiagnosis.
    van Luijt PA; Heijnsdijk EA; van Ravesteyn NT; Hofvind S; de Koning HJ
    J Med Screen; 2017 Jun; 24(2):83-91. PubMed ID: 27754936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. As you like it: How the same data can support manifold views of overdiagnosis in breast cancer screening.
    Njor SH; Paci E; Rebolj M
    Int J Cancer; 2018 Sep; 143(6):1287-1294. PubMed ID: 29633249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrapolation of pre-screening trends: Impact of assumptions on overdiagnosis estimates by mammographic screening.
    Ripping TM; Verbeek AL; Ten Haaf K; van Ravesteyn NT; Broeders MJ
    Cancer Epidemiol; 2016 Jun; 42():147-53. PubMed ID: 27153471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is overdiagnosis and why should we take it seriously in cancer screening?
    Carter SM; Barratt A
    Public Health Res Pract; 2017 Jul; 27(3):. PubMed ID: 28765855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overdiagnosis in the population-based organized breast cancer screening program estimated by a non-homogeneous multi-state model: a cohort study using individual data with long-term follow-up.
    Wu WY; Törnberg S; Elfström KM; Liu X; Nyström L; Jonsson H
    Breast Cancer Res; 2018 Dec; 20(1):153. PubMed ID: 30558679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit-to-harm ratio of the Danish breast cancer screening programme.
    Beau AB; Lynge E; Njor SH; Vejborg I; Lophaven SN
    Int J Cancer; 2017 Aug; 141(3):512-518. PubMed ID: 28470685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the magnitude of cancer overdiagnosis in Australia.
    Glasziou PP; Jones MA; Pathirana T; Barratt AL; Bell KJ
    Med J Aust; 2020 Mar; 212(4):163-168. PubMed ID: 31858624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of overdiagnosis using short-term trends and lead time estimates uncontaminated by overdiagnosed cases: Results from the Norwegian Breast Screening Programme.
    Michalopoulos D; Duffy SW
    J Med Screen; 2016 Dec; 23(4):192-202. PubMed ID: 26940963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term relationships between screening rates, breast cancer characteristics, and overdiagnosis in US counties, 1975-2009.
    Harding C; Pompei F; Burmistrov D; Wilson R
    Int J Cancer; 2019 Feb; 144(3):476-488. PubMed ID: 30264887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicians discuss ramifications of studies pointing to breast cancer overdiagnosis: New research under way attempts to better define who should be screened and treated.
    Printz C
    Cancer; 2017 Dec; 123(23):4525-4527. PubMed ID: 29149513
    [No Abstract]   [Full Text] [Related]  

  • 14. Overdiagnosis and overtreatment associated with breast cancer mammography screening: A simulation study with calibration to population-based data.
    Seigneurin A; Labarère J; François O; Exbrayat C; Dupouy M; Filippi M; Colonna M
    Breast; 2016 Aug; 28():60-6. PubMed ID: 27240167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revised estimates of overdiagnosis from the Canadian National Breast Screening Study.
    Baines CJ; To T; Miller AB
    Prev Med; 2016 Sep; 90():66-71. PubMed ID: 27374944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of pre-invasive disease in overdiagnosis: A microsimulation study comparing mass screening for breast cancer and cervical cancer.
    van Luijt PA; Rozemeijer K; Naber SK; Heijnsdijk EA; van Rosmalen J; van Ballegooijen M; de Koning HJ
    J Med Screen; 2016 Dec; 23(4):210-216. PubMed ID: 27068430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No overdiagnosis in the Norwegian Breast Cancer Screening Program estimated by combining record linkage and questionnaire information in the Norwegian Women and Cancer study.
    Lund E; Nakamura A; Thalabard JC
    Eur J Cancer; 2018 Jan; 89():102-112. PubMed ID: 29245077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of overdiagnosis by detection to incidence ratio in cancer screening.
    Hakama M; Malila N
    J Med Screen; 2019 Sep; 26(3):135-138. PubMed ID: 30987504
    [No Abstract]   [Full Text] [Related]  

  • 19. Quantifying Overdiagnosis in Cancer Screening: A Systematic Review to Evaluate the Methodology.
    Ripping TM; Ten Haaf K; Verbeek ALM; van Ravesteyn NT; Broeders MJM
    J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 29117353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The benefits and harms of breast cancer screening: an independent review.
    Independent UK Panel on Breast Cancer Screening
    Lancet; 2012 Nov; 380(9855):1778-86. PubMed ID: 23117178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.